Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration

被引：0
|
作者：
Paul E Simonsen
Yahya A Derua
Stephen M Magesa
Erling M Pedersen
Anna-Sofie Stensgaard
Mwelecele N Malecela
William N Kisinza
机构：
[1] Faculty of Health and Medical Sciences,Department of Veterinary Disease Biology
[2] University of Copenhagen,National Institute for Medical Research
[3] Amani Medical Research Centre,Global Health Division
[4] RTI International,Center for Macroecology
[5] Evolution and Climate,undefined
[6] Natural History Museum of Denmark,undefined
[7] University of Copenhagen,undefined
[8] National Institute for Medical Research,undefined
来源：
Parasites & Vectors | / 7卷
关键词：
Lymphatic filariasis; Wuchereria bancrofti; Control; Mass drug administration; Ivermectin; Albendazole; Microfilariae; Circulating filarial antigens; Vectors; Tanzania;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Mass drug administration to eliminate lymphatic filariasis in Southern India
    Pattanshetty, Sanjay
    Kumar, Ashwini
    Kumar, Ravi
    Rao, Chythra R.
    Badiger, Sanjeev
    Rashmi, R.
    Kamath, Sneha
    AUSTRALASIAN MEDICAL JOURNAL, 2010, 3 (13): : 847 - 850
  • [32] Inadvertent exposure of pregnant women to ivermectin and albendazole during mass drug administration for lymphatic filariasis
    Gyapong, JO
    Chinbuah, MA
    Gyapong, M
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2003, 8 (12) : 1093 - 1101
  • [33] PREVENTION OF LYMPHATIC FILARIASIS THROUGH MASS DRUG ADMINISTRATION PROGRAM: MAJOR HINDRANCES TO ITS EFFECTIVENESS IN ENDEMIC AREAS IN THE WESTERN REGION OF GHANA
    Ndabiah, Paul Armah
    Kicha, Dmitry
    Fomina, Anna
    ARCHIV EUROMEDICA, 2019, 9 (03): : 8 - 9
  • [34] Community perspectives on persistent transmission of lymphatic filariasis in three hotspot districts in Ghana after 15 rounds of mass drug administration: a qualitative assessment
    Ahorlu, Collins S. K.
    Koka, Eric
    Adu-Amankwah, Susan
    Otchere, Joseph
    de Souza, Dziedzom Komi
    BMC PUBLIC HEALTH, 2018, 18
  • [35] Surveillance for lymphatic filariasis after stopping mass drug administration in endemic districts of Togo, 2010-2015
    Dorkenoo, Monique Ameyo
    Bronzan, Rachel
    Yehadji, Degninou
    Tchalim, Maweke
    Yakpa, Kossi
    Etassoli, Santrao
    Adjeloh, Poukpessi
    Maman, Issaka
    Sodahlon, Yao
    PARASITES & VECTORS, 2018, 11
  • [36] Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia
    Bhullar, Navneet
    Maikere, Jacob
    PARASITES & VECTORS, 2010, 3
  • [37] Prevalence and risk factors associated with lymphatic filariasis in American Samoa after mass drug administration
    Coutts S.P.
    King J.D.
    Pa'au M.
    Fuimaono S.
    Roth J.
    King M.R.
    Lammie P.J.
    Lau C.L.
    Graves P.M.
    Tropical Medicine and Health, 45 (1)
  • [38] Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, Myanmar
    Benjamin F. R. Dickson
    Patricia M. Graves
    Ni Ni Aye
    Thet Wai Nwe
    Tint Wai
    San San Win
    Myint Shwe
    Janet Douglass
    Peter Wood
    Kinley Wangdi
    William J. McBride
    Parasites & Vectors, 14
  • [39] Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia
    Navneet Bhullar
    Jacob Maikere
    Parasites & Vectors, 3
  • [40] Side Benefits of Mass Drug Administration for Lymphatic Filariasis on Strongyloides stercoralis Prevalence on Pemba Island, Tanzania
    Barda, Beatrice
    Albonico, Marco
    Buonfrate, Dora
    Ame, Shaali M.
    Ali, Said
    Speich, Benjamin
    Keiser, Jennifer
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (03) : 681 - 683
12345